BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9517278)

  • 1. [Verapamil-associated liver injury].
    Odeh M; Oliven A
    Harefuah; 1998 Jan; 134(1):36-7. PubMed ID: 9517278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute asthma associated with sustained-release verapamil.
    Ben-Noun L
    Ann Pharmacother; 1997 May; 31(5):593-5. PubMed ID: 9161656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Verapamil toxicity: an unusual case report and review of the literature.
    Batalis NI; Harley RA; Schandl CA
    Am J Forensic Med Pathol; 2007 Jun; 28(2):137-40. PubMed ID: 17525564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of the mechanism of regression of left ventricular hypertrophy in hypertension treated with slow-release verapamil].
    Li G; Sun M; Zhou H
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(5):419-21, 424. PubMed ID: 10073024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Junctional bradycardia with verapamil in renal failure--care required even with mild hyperkalaemia.
    Hegazi MO; Aldabie G; Al-Mutairi S; El Sayed A
    J Clin Pharm Ther; 2012 Dec; 37(6):726-8. PubMed ID: 22568727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose initiation of calcium antagonists in the treatment of hypertension.
    Müller FB; Erne P; Hotz M; Bolli P; Follath F; Bühler FR
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):118S-124S. PubMed ID: 3794763
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous fat emulsion therapy for intentional sustained-release verapamil overdose.
    Young AC; Velez LI; Kleinschmidt KC
    Resuscitation; 2009 May; 80(5):591-3. PubMed ID: 19282085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Verapamil and hypertension--(multicenter study of the efficacy and tolerance of delayed-action verapamil in the treatment of essential hypertension)].
    Kreuter U; Mühlemann M; Vogt E; Wohlwend MC
    Rev Med Suisse Romande; 1990 Jun; 110(6):551-8. PubMed ID: 2195624
    [No Abstract]   [Full Text] [Related]  

  • 10. [Atrioventricular complete heart block developed due to verapamil use together with honey consumption].
    Onrat E; Kaya D; Barutçu I
    Anadolu Kardiyol Derg; 2003 Dec; 3(4):353-4. PubMed ID: 14675888
    [No Abstract]   [Full Text] [Related]  

  • 11. Massive overdose of sustained-release verapamil: a case report and review of literature.
    Ashraf M; Chaudhary K; Nelson J; Thompson W
    Am J Med Sci; 1995 Dec; 310(6):258-63. PubMed ID: 7503108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiocirculatory collapse after a single dose of sustained-release verapamil in a cirrhotic patient: usefulness of hyperinsulinaemia-euglycaemia therapy.
    Richard AL; Hantson P
    Anaesth Intensive Care; 2010 Mar; 38(2):398-400. PubMed ID: 20373536
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of intraportal verapamil infusion on hepatic ischemia-reperfusion injury.
    Erdoğan O; Yildiz S; Başaran A; Demirbaş A; Yeşilkaya A
    Pol J Pharmacol; 2001; 53(2):137-41. PubMed ID: 11787953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver injury due to verapamil.
    Burgunder JM; Abernethy DR; Lauterburg BH
    Hepatogastroenterology; 1988 Aug; 35(4):169-70. PubMed ID: 3181862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute toxic effects of sustained-release verapamil in chronic renal failure.
    Pritza DR; Bierman MH; Hammeke MD
    Arch Intern Med; 1991 Oct; 151(10):2081-4. PubMed ID: 1843183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of controlled-onset extended-release verapamil in middle-aged and older patients with hypertension and coronary artery disease.
    White WB; Johnson MF; Anders RJ; Elliott WJ; Black HR
    Am Heart J; 2001 Dec; 142(6):1010-5. PubMed ID: 11717605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of calcium channel blocker drugs in neuromuscular transmission.
    Ozkul Y
    Clin Neurophysiol; 2007 Sep; 118(9):2005-8. PubMed ID: 17644037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-arterial calcium channel blocker infusion for treatment of severe vasospasm in traumatic brain injury: case report.
    Lee DJ; Moftakhar P; Glenn TC; Vespa PM; Martin NA
    Neurosurgery; 2008 Nov; 63(5):E1004-6; discussion E1006. PubMed ID: 19005366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies with sustained-release verapamil in essential hypertension.
    Silke B
    Br J Clin Pract Suppl; 1988 Apr; 60():53-7. PubMed ID: 3151272
    [No Abstract]   [Full Text] [Related]  

  • 20. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
    Widimský J; Dzúrik R
    Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.